Curated News
By: NewsRamp Editorial Staff
July 06, 2026

SS Innovations Wins Outstanding Company at Surgical Robotics Awards

Discuss on LinkedIn Discuss on X, formerly Twitter Discuss on Telegram participate in discussion on bluesky Participate in discussion on Mastodon View History of this news story on GitHub
Original Source

TLDR

  • SS Innovations won Outstanding Company at the 2026 Surgical Robotics Industry Awards, beating nine rivals including established medtech firms.
  • SSI Mantra robotic system has completed 11,700+ procedures, received 14 country approvals, and trained 2,100+ physicians on 170+ procedures.
  • By enabling robotic surgery across 170 procedures, SS Innovations improves patient outcomes and expands access to minimally invasive care globally.
  • Over 11,700 procedures have been performed using the SSi Mantra system, which has regulatory approvals in 14 countries.

Impact - Why it Matters

This news matters because it highlights SS Innovations' growing credibility in the competitive surgical robotics market. With over 11,700 procedures completed and regulatory approvals in 14 countries, the SSi Mantra system is gaining traction, potentially improving patient outcomes and expanding access to minimally invasive surgery. For investors, the award signals a strong market position, while for healthcare providers, it offers a validated alternative to established robotic platforms.

Summary

SS Innovations International Inc. (NASDAQ: SSII), a developer of innovative surgical robotic technologies, has been named the winner of the Outstanding Company category at the 2026 Surgical Robotics Industry Awards (“SRIA”), receiving recognition from the industry organization for its work in developing and commercializing robotic surgery technology. The company was selected over nine other finalists, including several established medical technology companies active in robotic surgery. The award comes as adoption of the SSi Mantra surgical robotic system continues to expand, with more than 11,700 procedures completed globally. SSi Mantra has received regulatory approvals in 14 countries, supporting the company’s international growth strategy, and more than 2,100 physicians have been trained on the company’s robotic surgery platform, which has been used across more than 170 different procedures. For investors, the recognition provides an independent industry endorsement as SS Innovations continues to expand its presence in the rapidly growing global surgical robotics market.

The surgical robotics industry has become increasingly competitive as healthcare providers adopt robotic-assisted procedures across multiple specialties and manufacturers seek to expand beyond traditional markets. The award was presented to SS Innovations after the company was selected from a field of ten finalists. The news was disseminated by MissionIR, a specialized communications platform that is part of the Dynamic Brand Portfolio @ IBN, which delivers a wide range of services including access to a vast network of wire solutions via InvestorWire, editorial syndication to 5,000+ outlets, enhanced press release enhancement, and social media distribution to millions of followers. For more details, the latest news and updates relating to SSII are available in the company’s newsroom.

This recognition underscores SS Innovations' growing influence in the surgical robotics field, highlighting the SSi Mantra system's versatility across numerous procedures and its expanding global footprint. As the company continues to train physicians and gain regulatory approvals, the award serves as a catalyst for further adoption and investor confidence, positioning SS Innovations as a key player in the evolving landscape of robotic-assisted surgery.

Source Statement

This curated news summary relied on content disributed by InvestorBrandNetwork (IBN). Read the original source here, SS Innovations Wins Outstanding Company at Surgical Robotics Awards

blockchain registration record for this content.